Multiple endocrine neoplasia type 1 historical perspective: Difference between revisions
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) No edit summary |
||
Line 6: | Line 6: | ||
==Historical Perspective== | ==Historical Perspective== | ||
<br> | <br> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align= | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
|+'''''MEN I Historical Background'''''<ref name=omim>({{cite web |url=http://omim.org/entry/131100 |title=OMIM}}</ref> | |+'''''MEN I Historical Background'''''<ref name=omim>({{cite web |url=http://omim.org/entry/131100 |title=OMIM}}</ref> | ||
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Years}} | ! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Years}} |
Revision as of 14:29, 14 September 2015
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 historical perspective On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 historical perspective |
FDA on Multiple endocrine neoplasia type 1 historical perspective |
CDC on Multiple endocrine neoplasia type 1 historical perspective |
Multiple endocrine neoplasia type 1 historical perspective in the news |
Blogs on Multiple endocrine neoplasia type 1 historical perspective |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [3]
Overview
Multiple endocrine neoplasia type 1 was first described by Dr. Erdheim, a German physician, in 1903 by reporting a case of an acromegalic patient with pituitary adenoma and three enlarged parathyroid glands.
Historical Perspective
Years | Scientist | Contribution |
---|---|---|
1903 | Erdheim | Reported case of an acromegalic patient with pituitary adenoma and three enlarged parathyroid glands |
1953 | Underdahl | Reported case series of patients with syndrome of pituitary, parathyroid, and pancreatic islet adenomas |
1954 | Wermer | Identified that multiple endocrine neoplasia was transmitted as a dominant trait |
1962 | Williams and Celestin | First described bronchial carcinoid as a feature of multiple endocrine neoplasia type 1 |
1963 | Jacobs and Underwood | Reported case of hypoglycemia and islet cell adenomas in 3 members of the family, with father having hyperparathyroidism and broncial carcinoma and son and daughter with idiopathic epilepsy[2] |
1966 | Guida | Identified pituitary adenoma and duodenal carcinoid in patients with multiple endocrine neoplasia type 1 syndrome[3] |
1967 | Johnson | Presented a multiple endocrine neoplasia type 1 case devoid of peptic ulcer[4] |
1968 | Steiner | Introduced the term "multiple endocrine neoplasia" (MEN) to describe disorders featuring combinations of endocrine tumors and proposed the terms 'Wermer syndrome' for multiple endocrine neoplasia type 1 and 'Sipple syndrome' for multiple endocrine neoplasia type 2 |
1972 | Vance | Suggested the importance of primary genetic lesion in endocrine adenomatosis in developing neoplasia and hyperfunctioning of islet of langerhans[5] |
1982 | McCarthy | Identified 2 different causes of Zollinger-Ellison syndrome, malignant type and the one linked with multiple endocrine neoplasia type 1[6] |
1983 | Hershon | Identified family members from Pacific Northwest with prolactinomas but with no pancreatic tumors |
1985 | Bear | Referred the disorders reported from Burin as multiple endocrine neoplasia type 1 Burin |
1986 | Brandi | Suggested the humoral cause of primary hyperparathyroidism in familial multiple endocrine neoplasia type 1 |
1986 | Schimke | Suggested a 2 step model of pathogenesis which include germline mutation followed by somatic mutation later |
1986 | Bahn | Identified 25 year old monozygotic twins with one having primary hyperparathyroidism, Zollinger-Ellison syndrome, cushing's disease, and hyperprolactinemia and the other have primary hyperparathyroidism and hyperprolactinemia[7] |
1986 | Maton | Identified that cushing's syndrome is more common with Zollinger-Ellison syndrome[8] |
1988 | The multiple endocrine neoplasia type 1 locus was assigned to chromosome 11 (11q13) | |
1993 | Gaitan | Described mother and daughter with cushing's disease due to ACTH secreting tumor[9] |
1994 | Petty | Identified that gene involved in Pacific Northwest studies and Burin studies linked to 11q chromosome |
1997 | Darling | Suggested that one of the diagnostic findings of multiple endocrine neoplasia type 1 is cutaneous manifestations |
1998 | The multiple endocrine neoplasia type 1 gene was cloned[10] | |
1999 | Yu | Identified that gastrinoma growth is the single most important factor in deciding the long term survival of patients with Zollinger-Ellison syndrome[11] |
2001 | Bordi | Identified patients with multiple endocrine neoplasia syndrome to have carcinoid tumors[12] |
References
- ↑ ("OMIM".
- ↑ UNDERWOOD LE, JACOBS NM (1963). "FAMILIAL ENDOCRINE ADENOMATOSIS. A FAMILY WITH HYPERINSULINISM AS THE PREDOMINANT MANIFESTATION". Am J Dis Child. 106: 218–23. PMID 14056823.
- ↑ Guida PM, Todd JE, Mooe SW, Beal JM (1966). "Zollinger-Ellison syndrome with interesting variations. Report of twelve cases including one of carcinoid of the duodenum". Am J Surg. 112 (6): 807–17. PMID 4288594.
- ↑ Johnson GJ, Summerskill WH, Anderson VE, Keating FR (1967). "Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis". N Engl J Med. 277 (26): 1379–85. doi:10.1056/NEJM196712282772601. PMID 4384073.
- ↑ [1] MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
- ↑ McCarthy DM (1982). "Zollinger-Ellison syndrome". Annu Rev Med. 33: 197–215. doi:10.1146/annurev.me.33.020182.001213. PMID 7044271.
- ↑ Bahn RS, Scheithauer BW, van Heerden JA, Laws ER, Horvath E, Gharib H (1986). "Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins". Mayo Clin Proc. 61 (9): 689–96. PMID 2875227.
- ↑ Maton PN, Gardner JD, Jensen RT (1986). "Cushing's syndrome in patients with the Zollinger-Ellison syndrome". N Engl J Med. 315 (1): 1–5. doi:10.1056/NEJM198607033150101. PMID 2872593.
- ↑ Gaitan D, Loosen PT, Orth DN (1993). "Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I." J Clin Endocrinol Metab. 76 (6): 1580–2. doi:10.1210/jcem.76.6.8099078. PMID 8099078.
- ↑ Guru SC, Manickam P, Crabtree JS, Olufemi SE, Agarwal SK, Debelenko LV. Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene. J Intern Med 243(6) 433-9
- ↑ Yu F, Venzon DJ, Serrano J, Goebel SU, Doppman JL, Gibril F; et al. (1999). "Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome". J Clin Oncol. 17 (2): 615–30. PMID 10080607.
- ↑ Bordi C, Corleto VD, Azzoni C, Pizzi S, Ferraro G, Gibril F; et al. (2001). "The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes". J Clin Endocrinol Metab. 86 (5): 2236–42. doi:10.1210/jcem.86.5.7479. PMID 11344233.